...
首页> 外文期刊>Nature neuroscience >M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
【24h】

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

机译:M2小胶质细胞和巨噬细胞在CNS髓鞘再生期间驱动少突胶质细胞分化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The lack of therapies for progressive multiple sclerosis highlights the need to understand the regenerative process of remyelination that can follow CNS demyelination. This involves an innate immune response consisting of microglia and macrophages, which can be polarized to distinct functional phenotypes: pro-inflammatory (M1) and anti-inflammatory or immunoregulatory (M2). We found that a switch from an M1- to an M2-dominant response occurred in microglia and peripherally derived macrophages as remyelination started. Oligodendrocyte differentiation was enhanced in vitro with M2 cell conditioned media and impaired in vivo following intra-lesional M2 cell depletion. M2 cell densities were increased in lesions of aged mice in which remyelination was enhanced by parabiotic coupling to a younger mouse and in multiple sclerosis lesions that normally show remyelination. Blocking M2 cell-derived activin-A inhibited oligodendrocyte differentiation during remyelination in cerebellar slice cultures. Thus, our results indicate that M2 cell polarization is essential for efficient remyelination and identify activin-A as a therapeutic target for CNS regeneration.
机译:缺乏进行性多发性硬化症的治疗方法,突显了对了解中枢神经系统脱髓鞘后再生髓鞘再生过程的需要。这涉及由小胶质细胞和巨噬细胞组成的先天免疫应答,它们可以极化为不同的功能表型:促炎性(M1)和抗炎性或免疫调节(M2)。我们发现,随着髓鞘再生的开始,在小胶质细胞和外周来源的巨噬细胞中发生了从M1到M2显性反应的转换。病变内M2细胞耗竭后,体外M2细胞条件培养基可增强少突胶质细胞的分化,并在体内受损。 M2细胞密度在老年小鼠的病变中增加,其中通过与幼鼠的共生生物偶联而使髓鞘再生增强,在正常显示髓鞘再生的多发性硬化症病变中。在小脑切片培养物中,髓鞘再生过程中阻断M2细胞来源的激活素A抑制少突胶质细胞分化。因此,我们的结果表明,M2细胞极化对于有效的髓鞘再生至关重要,并将激活素A鉴定为CNS再生的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号